Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Circulation Journal

• Publication date

  2002-11-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1253/CIRCJ.66.1087PMID 12499611
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) II: associated risk factorin

  2004cited by this paper
• Coronary Heart Disease Mortality Among Men Aged 35-44 Years by Prefecture in Japan in 1995-1999 Compared With That Among White Men Aged 35-44 by State in the United States in 1995-1998

  2001cited by this paper
• Serum triglycerides and risk of coronary heart disease among Japanese men and women.

  2001cited by this paper
• Efficacy of cholesterol lowering therapy on the prognosis of Japanese patients with coronary artery disease

  2001cited by this paper
• Coronary heart disease mortality among men aged 35-44 years by prefecture in Japan in 1995-1999 compared with that among white men aged 35-44 by state in the United States in 1995-1998: vital statistics data in recent birth cohort.

  2001cited by this paper
• High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High--Density Lipoprotein Intervention Trial.

  2000cited by this paper
• Risk factors that discriminate 'high- risk' from 'low-risk' Japanese patients with coronary artery disease.

  2000cited by this paper
• Alcohol consumption and risk of coronary heart disease by diabetes status.

  2000cited by this paper
• Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus.

  2000cited by this paper
• Design and baseline characteristics of a cohort study in Japanese patients with hypercholesterolemia: the Japan lipid intervention trial (J-LIT)

  2000cited by this paper
• Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease.

  1999cited by this paper
• Effect of statins on C-reactive protein in patients with coronary artery disease.

  1999cited by this paper
• Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).

  1999cited by this paper
• Relationship between serum cholesterol and the risk of acute myocardial infarction in a screened cohort in Okinawa, Japan.

  1998cited by this paper
• Alcohol intake and premature coronary heart disease in urban Japanese men.

  1998cited by this paper
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• The emergence of triglycerides as a significant independent risk factor in coronary artery disease.

  1998cited by this paper
• The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers.

  1997cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month.

  1997cited by this paper
• The relation of chronic diseases to all-cause mortality risk--the Seven Countries Study.

  1997cited by this paper
• The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

  1996cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• [The Scandinavian Simvastatin Survival Study (4S)].

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan 1980-1989.

  1993cited by this paper
• Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733).

  1992cited by this paper
• Health policy on blood cholesterol. Time to change directions.

  1992cited by this paper
• Statement on smoking and cardiovascular disease for health care professionals. American Heart Association.

  1992cited by this paper
• Prospective study of alcohol consumption and risk of coronary disease in men.

  1991cited by this paper
• Smoking and mortality among older men and women in three communities.

  1991cited by this paper
• Trend of coronary heart disease and its relationship to risk factors in a Japanese population: a 26-year follow-up, Hiroshima/Nagasaki study.

  1990cited by this paper
• A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: causes and death rates

  1990cited by this paper
• Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond.

  1989cited by this paper
• Reducing the Health Consequences of Smoking: 25 Years of Progress. A Report of the Surgeon General.

  1989cited by this paper
• A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women.

  1988cited by this paper
• Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease — putative association via common antecedents; further evidence from the whitehall study

  1988cited by this paper
• Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.

  1987cited by this paper
• Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial.

  1987cited by this paper
• Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes.

  1987cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper
• Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus.

  1987cited by this paper
• Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT. Multiple Risk Factor Intervention Trial.

  1986cited by this paper
• Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

  1986cited by this paper
• Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

  1986cited by this paper
• Mortality from coronary heart disease in the Tecumseh study. Long-term effect of diabetes mellitus, glucose tolerance and other risk factors.

  1985cited by this paper
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.

  1984cited by this paper
• The seven countries study: 2,289 deaths in 15 years.

  1984cited by this paper
• The Bedford Survey: Ten year mortality rates in newly diagnosed diabetics, borderline diabetics and normoglycaemic controls and risk indices for coronary heart disease in borderline diabetics

  1982cited by this paper
• Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

  1980cited by this paper
• A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate.

  1979cited by this paper
• A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

  1978cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper

• Potential Benefits and Risks Associated with the Use of Statins

  2024cites this paper
• JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease.

  2024cites this paper
• Cuban policosanol improves high-density lipoprotein cholesterol efflux capacity in healthy Japanese subjects

  2024cites this paper
• Safety and Effectiveness of Low‐Density Lipoprotein Cholesterol–Lowering Therapy With Evolocumab for Familial Hypercholesterolemia/Hypercholesterolemia in Japan: A Real‐World, Postmarketing, Single‐Arm Study

  2024cites this paper
• Targeting Conserved Pathways in 3D Spheroid Formation of Diverse Cell Types for Translational Application: Enhanced Functional and Antioxidant Capacity

  2023cites this paper
• Raman imaging and chemometric methods in human normal bronchial and cancer lung cells: Raman biomarkers of lipid reprogramming.

  2023cites this paper
• Role of Small Dense Low-density Lipoprotein Cholesterol in Cardiovascular Events in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Receiving Statin Treatment

  2023cites this paper
• Assessing the Highest Level of Evidence from Randomized Controlled Trials in Omega-3 Research

  2023cites this paper
• Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

  2023cites this paper
• Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target

  2022cites this paper
• Prevalence of statin intolerance: a meta-analysis

  2022cites this paper
• Bird's eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes.

  2022cites this paper
• Commentary: Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential

  2022cites this paper
• Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer

  2021cites this paper
• Associations of cardiovascular risk factors with survival outcomes in a cancer registration

  2021cites this paper
• Anesthesia and Cancer Recurrence

  2021cites this paper
• DHCR24 Promotes Melanoma Stem-Like Cells Formation and Mediates Vemurafenib Resistance by Accumulating 27-Hydroxycholesterol

  2021cites this paper
• The Circulation Journal Official Impact Factor and the Most Frequently Cited Papers in 2020.

  2021cites this paper
• Biochemical risk factors of atherosclerotic cardiovascular disease: from a narrow and controversial approach to an integral approach and precision medicine

  2021cites this paper
• Variants Near CETP, MTTP and BUD13-ZPR1-APOA5 may be Nominally Associated with Poor Statin Response Among Filipinos

  2021cites this paper
• The new European guidelines for prevention of cardiovascular disease are misleading

  2020cites this paper
• Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease.

  2020cites this paper
• The Effects of Teneligliptin on Lipid Profile: A Prospective Study for Comparison of Biomarkers Before and After a Meal

  2020cites this paper
• Message From the Editor-in-Chief.

  2020cites this paper
• Obesity and Cancer: 27-Hydroxycholesterol, the Missing Link

  2020cites this paper
• Usefulness of Plasma Branched-Chain Amino Acid Analysis in Predicting Outcomes of Patients with Nonischemic Dilated Cardiomyopathy.

  2020cites this paper
• Prevalence Trend for 31 Years of Hypertriglyceridemia in Ningen Dock and Resetting of Medical Examination Recommendations through Evaluation of Improvement for Hypertriglyceridemia with Weight Loss

  2020cites this paper
• Is lipid goal one-size-fits-all: A review of evidence for recommended low-density lipoprotein treatment targets in Asian patients

  2019cites this paper
• Total cholesterol and mortality from ischemic heart disease and overall cardiovascular disease in Korean adults

  2019cites this paper
• Reprogramming of fatty acid metabolism in cancer

  2019cites this paper
• The role of cholesterol metabolism in cancer.

  2019cites this paper
• A Critical Review of the Consensus Statement from the European Atherosclerosis Society Consensus Panel 2017

  2018cites this paper
• Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus

  2018cites this paper
• Therapeutic targeting of lipid synthesis metabolism for selective elimination of cancer stem cells

  2018cites this paper
• Endothelial Dysfunction, Increased Arterial Stiffness, and Cardiovascular Risk Prediction in Patients With Coronary Artery Disease: FMD‐J (Flow‐Mediated Dilation Japan) Study A

  2018cites this paper
• Treatment patterns in hyperlipidaemia patients based on administrative claim databases in Japan.

  2018cites this paper
• Strokes, cholesterol and statins: When mortality is an endpoint.

  2018cites this paper
• Response to Comment on Itoh et al. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. Diabetes Care 2018;41:1275–1284

  2018cites this paper
• Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

  2018cites this paper
• Low-Density Lipoprotein Cholesterol Goal Attainment Rates by Initial Statin Monotherapy Among Patients With Dyslipidemia and High Cardiovascular Risk in Japan　- A Retrospective Database Analysis.

  2018cites this paper
• Extending the “Lower is Better” Principle to Japanese and Possibly Other Asian Populations

  2018cites this paper
• Comment on Itoh et al. Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study. Diabetes Care 2018;41:1275–1284

  2018cites this paper
• Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis

  2017cites this paper
• Pitavastatin and HDL: Effects on plasma levels and function(s).

  2017cites this paper
• Impact of Adding Eicosapentaenoic Acid to Statin Therapy on Plasma Pentraxin 3 Level in Patients with Stable Coronary Artery Disease: A 6-Month, Randomized Controlled Study

  2017cites this paper
• Message from the Editor-in-Chief

  2017cites this paper
• Treat-to-target lipid control is effective but highlighted poor prognosis without indication of statin following percutaneous coronary intervention

  2017cites this paper
• Low-dose statin treatment increases prostate cancer aggressiveness

  2017cites this paper
• Comment on ‘Statin use and all-cancer survival: prospective results from the Women's Health Initiative'

  2017cites this paper
• Is High Serum LDL/HDL Cholesterol Ratio an Emerging Risk Factor for Sudden Cardiac Death? Findings from the KIHD Study

  2017cites this paper
• Safety of atorvastatin in Asian patients within clinical trials

  2016cites this paper
• 飲酒習慣のある男性喫煙者における飲酒量、喫煙本数、運動習慣がHDLコレステロールに与える影響

  2016cites this paper
• Lower 1,5-anhydroglucitol is associated with adverse clinical events after percutaneous coronary intervention

  2016cites this paper
• Efficacy and Safety of Alirocumab in Japanese Subjects (Phase 1 and 2 Studies).

  2016cites this paper
• Risk of statin therapy in elderly.

  2016cites this paper
• The Role of Cholesterol in Cancer.

  2016cites this paper
• Serum high-density lipoprotein cholesterol ( HDL-The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population

  2016cites this paper
• Synergistic effect of atorvastatin and cyanidin-3-glucoside against angiotensin II-mediated vascular smooth muscle cell proliferation and migration through MAPK and PI3K/Akt pathways

  2016cites this paper
• The relationship between cholesterol concentration and carotid intima media thickness differs according to gender and menopausal status in Korean type 2 diabetic patients.

  2016cites this paper
• Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project

  2016cites this paper
• Evaluation of the Lipid Concentrations after Switching from Antiretroviral Drug Tenofovir Disoproxil Fumarate/Emtricitabine to Abacavir Sulfate/Lamivudine in Virologically-suppressed Human Immunodeficiency Virus-infected Patients

  2016cites this paper
• Cholesterol Metabolism and Its Role in Cancer

  2016cites this paper
• Message from the editor-in-chief.

  2015cites this paper
• Statins do not protect against cancer: quite the opposite.

  2015cites this paper
• Unique Features of High-Density Lipoproteins in the Japanese: In Population and in Genetic Factors

  2015cites this paper
• Message From the Editor-in-Chief.

  2015cites this paper
• Message From the Editor-in-Chief.

  2015cites this paper
• Different Impacts of Cardiovascular Risk Factors on Arterial Stiffness versus Arterial Wall Thickness in Japanese Patients with Type 2 Diabetes Mellitus.

  2015cites this paper
• [Risk factors for ischemic heart disease in males in the prime of life: An eight-year follow-up study].

  2015cites this paper
• Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.

  2015cites this paper
• Statin-induced low low-density lipoprotein cholesterol level: is lower better?

  2015cites this paper
• Association between SLCO1B1 521 T＞C and 388 A＞G Polymorphisms and Statins Effectiveness: A Meta-Analysis.

  2015cites this paper
• Association between fasting plasma triglycerides, all-cause and cardiovascular mortality in Czech population. Results from the HAPIEE study.

  2015cites this paper
• Lipid and blood pressure control for the prevention of cardiovascular disease in hypertensive patients: a subanalysis of the OMEGA study.

  2015cites this paper
• Impact of gastrectomy on high-density lipoprotein cholesterol elevation in nonobese patients during a 10-year follow-up.

  2015cites this paper
• Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms

  2015cites this paper
• Message From the Editor-in-Chief.

  2015cites this paper
• Statins stimulate atherosclerosis and heart failure: pharmacological

  2015cites this paper
• Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease

  2014cites this paper
• Erratum: The Relationship Between Low-Density Lipoprotein Cholesterol Levels and the Incidence of Cardiovascular Disease in High-Risk Patients Treated With Pravastatin

  2014cites this paper
• Consensus statement on management of dyslipidemia in Indian subjects.

  2014cites this paper
• Effects of Carbohydrate and Dietary Fiber Intake, Glycemic Index and Glycemic Load on HDL Metabolism in Asian Populations

  2014cites this paper
• Obesity Diabetes mellitus Oral estrogens ; selective estrogen receptor modulators Physical inactivity Polycystic ovary syndrome Beta-blockers Diet high in fat and simple sugars Hypothyroidism Thiazides Excessive alcohol consumption Nephrotic syndrome , chronic renal disease Atypical antipsychotics C

  2014cites this paper
• Effect of pravastatin on endothelial dysfunction in children with medium to giant coronary aneurysms due to Kawasaki disease

  2014cites this paper
• The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014)

  2014cites this paper
• Validation of homogeneous assays for HDL-cholesterol using fresh samples from healthy and diseased subjects.

  2014cites this paper
• Effect of Alogliptin, a DPP-4 Inhibitor, on Markers of Lipid Metabolism in Type 2 Diabetic Patients

  2014cites this paper
• Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study risk factor sub-analysis

  2014cites this paper
• The relationship between low-density lipoprotein cholesterol levels and the incidence of cardiovascular disease in high-risk patients treated with pravastatin: main results of the APPROACH-J study.

  2014cites this paper
• Recent advances in pharmacotherapy for hypertriglyceridemia.

  2014cites this paper
• Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.

  2014cites this paper
• Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.

  2014cites this paper
• Status of diabetes treatment in Japanese adults: an analysis of the 2009 Japan Society of Ningen Dock database.

  2014cites this paper
• Disease duration and severity impacts on long-term cardiovascular events in Japanese patients with rheumatoid arthritis.

  2014cites this paper
• Coronary artery disease. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

  2014cites this paper
• The combination of the ankle brachial index and brachial ankle pulse wave velocity exhibits a superior association with outcomes in diabetic patients.

  2014cites this paper
• Statins and the risks of stroke recurrence and death after ischemic stroke: the Fukuoka Stroke Registry.

  2013cites this paper
• Antihyperlipidemic and antiatherogenic activity of simvastatin may involve modulation of the expression of lecithin:cholesterol acyl transferase.

  2013cites this paper
• The association between obesity and acute myocardial infarction is age- and gender-dependent in a Japanese population

  2013cites this paper
• Other types of primary hyperlipoproteinemia(hyperlipidemia). Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan--2012 version.

  2013cites this paper